Home

Basic Information

Trade Type

Sell

Product Name

BFS-Neostigmine 0.5

Registered Market

Specifications

  • Dosage Form: Solution injection
  • Packaging: Box 10 ampoule x 1 mL; box 20 ampoule x 1 mL; box 50 ampoule x 1 mL
  • Strength: 0,5mg
  • Standards: In-house standard
  • Shelf Life: 36 month

Documents

Drug Marketing Authorization Number
Document No.: VD-24009-15
Issue Date: Dec 20, 2022
Expiry Date: Dec 20, 2027
Note: 833/QĐ-QLD | 181
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product